Artivion | CRY - الأصول





الأصول تغيير تاريخ
Abbott USD 110.43B 23.72B 2026-03
Accuray USD 448.01M 8.81M 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 883.16M 1.64M 2026-03
AtriCure USD 643.99M 10.19M 2026-03
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Inogen USD 307.01M 5.03M 2025-09
Integra LifeSciences USD 3.58B 24.28M 2026-03
J&J USD 200.89B 1.68B 2026-03
Mesa Laboratories USD 434.85M 4.5M 2025-12
Orthofix International USD 886.6M 35.95M 2026-03
Pfizer USD 207.62B 542M 2026-03
ResMed USD 8.78B 280.91M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Surmodics USD 169.82M 8.74M 2025-06
Tandem Diabetes Care USD 1.15B 272.28M 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Terumo JPY 2.31T 55.3B 2026-03
Trinity Biotech USD 103.71M 4.08M 2025-09